For healthcare providers treating cholangiocarcinoma, mutations matter.

For healthcare providers treating patients with cholangiocarcinoma, molecular profiling may provide access to effective treatment options. Consider making molecular profiling part of your standard protocol for cholangiocarcinoma patients.

cholangiocarcinoma,bile duct cancer,molecular profiling,mutations matter,ccf,cca,cholangiocarcinoma foundation,clinical trials,